Open-label study of the short-term effects of memantine on FDG-PET in frontotemporal dementia

BACKGROUND: Memantine has shown effects on cortical metabolism in Alzheimer’s disease (AD), and the mechanism of action may not be specific to AD alone. We hypothesized that participants with frontotemporal dementia taking memantine would show an increased cortical metabolic activity in frontal regi...

Descripció completa

Guardat en:
Dades bibliogràfiques
Autors principals: Chow, Tiffany W, Graff-Guerrero, Ariel, Verhoeff, Nicolaas PLG, Binns, Malcolm A, Tang-Wai, David F, Freedman, Morris, Masellis, Mario, Black, Sandra E, Wilson, Alan A, Houle, Sylvain, Pollock, Bruce G
Format: Artigo
Idioma:Inglês
Publicat: Dove Medical Press 2011
Matèries:
Original Research
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC3140294/
https://ncbi.nlm.nih.gov/pubmed/21792308
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/NDT.S22635
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars